Top

European Archives of Oto-Rhino-Laryngology

Published in:

01-08-2015 | Head and Neck

Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma

Authors: A. Boehm, F. Lindner, G. Wichmann, U. Bauer, C. Wittekind, M. Knoedler, F. Lordick, S. Dietzsch, M. Scholz, R. Kortmann, A. Dietz

Published in: European Archives of Oto-Rhino-Laryngology | Issue 8/2015

Abstract

Based on level I evidence, postoperative platinum-based radiochemotherapy (PORCT) is the recommended standard of care in defined risk situations after resection of squamous cell carcinomas of the larynx and hypopharynx (LHSCC). The value of the addition of chemotherapy to adjuvant radiation in intermediate and high risk situations other than extracapsular spread or R1-/R2 resection is still debated. From 1993 to 2009, 555 patients (median follow-up: 24.4 months) with advanced LHSCC (UICC stages III–IVB) were treated in a curative intent. Patient data were continuously documented in the county of Leipzig cancer registry and were retrospectively analyzed as mono institutional survey. PORCT was introduced into the standard procedures in 2004, but also applied before in selected cases. Based on this paradigm shift, the patient population was divided into two comparative groups treated before and after 2004. 361 patients were treated before 2004. 43.8 % received primary surgery (OP) + postoperative radiotherapy (PORT) and 20.2 % OP + PORCT. 194 patients were treated after 2004: 21.1 % received OP + PORT and 35.6 % OP + PORCT. Regarding the PORCT groups, 20.6 % received cisplatin plus 5FU before 2004 which shifted to 59.4 % after 2004. The 3-year tumor-specific-survival rate of the whole cohort was improved from 47 to 60 % (p = 0.006). The subgroup treated with OP + PORT or PORCT improved from 56.1 to 68.5 % (p = 0.028). Localization proved to be a significant and independent factor. Only patients with advanced laryngeal cancer had significant improved survival (p < 0.01), while the improvement for hypopharyngeal cancer patients was not significant (p < 0.2). After 2004, there was a slight increase (+10.2 %) of primary radiochemotherapy (pRCT) due to stronger selection if R0 > 5 mm-resectability is unlikely. Standardised use of PORCT and pRCT considering clear indications showed to be significantly involved in improved survival in advanced LHSCC.

Sobin LH, Gospodarowicz MK, Wittekind Ch (2009) UICC: TNM classification of malignant tumors, 7th edn. Wiley-Blackwell, Oxford

Wittekind Ch, Meyer H-J (2010) TNM Klassifikationen maligner Tumoren, 7th edn. Wiley-VCH, Weinheim

Quon H, O’Malley BW Jr, Weinstein GS (2011) Postoperative adjuvant therapy after transoral robotic resection for oropharyngeal carcinomas: rationale and current treatment approach. ORL J Otorhinolaryngol Relat Spec 73(3):121–130PubMedCrossRef

Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952PubMedCrossRef

Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944PubMedCrossRef

Fietkau R, Lautenschläger C, Sauer R, Dunst J, Becker A, Baumann M, Wendt T, Grüschow K, Hess C, Budach V, Iro H. (2006) Postoperative concurrent radiochemotherapy versus radiotherapy in high-risk SCCA of the head and neck: results of the German phase III trial ARO 96-3. J Clin Oncol. 24, 18S: Abstract No 5507

Pivot X, Kataja VV, Jelic S, Force ESMO (2005) Guidelines task. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN). Ann Oncol 16(Suppl 1):i62–i63PubMedCrossRef

Dietz A (2010) Kopf-Hals-Tumoren––Therapie des Larynx/hypopharynxkarzinoms unter besonderer Berücksichtigung des Larynxorganerhalts. UNI-MED, Bremen-London-Boston

Peters LJ, Goepfert H, Ang KK, Byers RM, Maor MH, Guillamondegui O, Morrison WH, Weber RS, Garden AS, Frankenthaler RA et al (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26(1):3–11PubMedCrossRef

10.

Pfreundner L, Willner J, Marx A, Hoppe F, Beckmann G, Flentje M (2000) The influence of the radicality of resection and dose of postoperative radiation therapy on local control and survival in carcinomas of the upper aerodigestive tract. Int J Radiat Oncol Biol Phys 47(5):1287–1297PubMedCrossRef

11.

Fan KH, Wang HM, Kang CJ, Lee LY, Huang SF, Lin CY, Chen EY, Chen IH, Liao CT, Chang JT (2010) Treatment results of postoperative radiotherapy on squamous cell carcinoma of the oral cavity: coexistence of multiple minor risk factors results in higher recurrence rates. Int J Radiat Oncol Biol Phys 77(4):1024–1029PubMedCrossRef

12.

Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27(10):843–850PubMedCrossRef

13.

Bourhis J, Le Maître A, Baujat B, Audry H, Pignon JP (2007) Individual patients’ data meta-analyses in head and neck cancer. Curr Opin Oncol 19(3):188–194PubMedCrossRef

14.

Pignon JP, le Maître A, Maillard E, Bourhis J und Group, MACH-NC (2009) Collaboration. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92(1):4–14CrossRef

15.

Wolf GT, Urba S, Hazuka M (1994) Induction chemotherapy for organ preservation in advanced squamous cell carcinoma of the oral cavity and oropharynx. Recent Results Cancer Res 134:133–143PubMed

16.

Forastiere AA, Trotti A, Pfister DG, Grandis JR (2006) Head and neck cancer: recent advances and new standards of care. J Clin Oncol 24(17):2603–2605PubMedCrossRef

17.

Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, Blot E, Rives M, Reyt E, Tourani JM, Geoffrois L, Peyrade F, Guichard F, Chevalier D, Babin E, Lang P, Janot F, Calais G, Garaud P, Bardet E (2013) Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. J Clin Oncol 31(7):853–859PubMedCrossRef

18.

Trotti A, Pajak TF, Gwede CK, Paulus R, Cooper J, Forastiere A, Ridge JA, Watkins-Bruner D, Garden AS, Ang KK, Curran W (2007) TAME: Development of a new method for summarising adverse events of cancer treatment by the radiation therapy oncology group. Lancet Oncol 7:613–624CrossRef

19.

Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589PubMedCrossRef

20.

Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Lustig R, Ensley JF, Thorstad W, Schultz CJ, Yom SS, Ang KK (2012) Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 84(5):1198–1205PubMedCentralPubMedCrossRef

21.

Altmann U, Katz FR, Tafazzoli AG, Haeberlin V, Dudeck J (1996) GTDS––a tool for tumor registries to support shared patient care. Proc AMIA Annu Fall Symp 512-6

22.

Altmann U, Katz FR, Dudeck J (2006) A reference model for clinical tumour documentation. Stud Health Technol Inform. 124:139–144PubMed

23.

Dietz A Randomised Phase II Screening Study to be Used in an TP/TPF-chemotherapy (Short Induction) Before TP/TPF-induction, Radiotherapy With or Without Cetuximab in the Primary Therapy of the Only by Laryngectomy Operable Carcinoma of the Larynx/Hypopharynx. ClinicalTrials.gov. NCT-Identifier: NCT00508664 2007

24.

Dietz A, Flentje M, Hagen R, Kortmann RD, Hildebrand G, Hoppe F, Schwienhorst I, Keilholz U (2010) Docetaxel, cisplatin (TP), and radiation with or without cetuximab in advanced larynx carcinoma (DeLOS II trial). J Clin Oncol 28:15 s (suppl; abstr TPS265)

25.

Marta GN, Silva V, de Andrade Carvalho H, de Arruda FF, Hanna SA, Gadia R, da Silva JL, Correa SF, Vita Abreu CE, Riera R (2013) Intensity-modulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol. pii: S0167-8140(13)00616-6

26.

Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S, Murthy V, Budrukkar A, Dinshaw K, Prabhash K, Chaturvedi P, D’Cruz A (2012) Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 104(3):343–348PubMedCrossRef

Title: Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma
Authors: A. Boehm
F. Lindner
G. Wichmann
U. Bauer
C. Wittekind
M. Knoedler
F. Lordick
S. Dietzsch
M. Scholz
R. Kortmann
A. Dietz
Publication date: 01-08-2015
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 8/2015
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-014-3134-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Impact of indication-shift of primary and adjuvant chemo radiation in advanced laryngeal and hypopharyngeal squamous cell carcinoma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2015

The role of elastography in evaluating thyroid nodules: a literature review and meta-analysis

Correlation analysis of STAT3 and VEGF expression and eosinophil infiltration in nasal polyps

Association of history of allergies and influenza-like infections with laryngeal cancer in a case–control study

Diagnosis and management of multiple paragangliomas of the head and neck

Treatment of base of tongue cancer, stage III and stage IV with primary surgery: survival and functional outcomes

Evaluation of a minimally invasive surgical fixation technique for young children with the Concerto Pin cochlear implant system